RA CAPITAL MANAGEMENT, L.P. received a stock award from ACUMEN PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/18/2026ACC: 0001231919-26-000262
Director10% Owner
Since Jun 2021
+6.06M
Net shares
Net buyer
$20.00M
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
6.06M acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+6.06M
Price / share
$3.30
Trade value
$20M
% of position
46.5%
3/16/2026
13.04M→19.10M
Total
Net shares
+6.06M
Net value
$20M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/16/2026 | A · Award | +6.06M | $3.30 | $20M | 46.5% | 13.04M | 19.10M |
| Total | +6.06M | $20M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned1.30M
Common Stock
IndirectShares owned588.85K
Total
1.89M indirect1.89M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.30M | Indirect |
| Common Stock | 588.85K | Indirect |
| Total | 1.89M | 1.89M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported